- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Granules India Ltd (GRAN)
Granules India Ltd stock price live, this page displays NSE GRAN stock exchange data. View the GRAN premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Granules India Ltd real time stock price chart below.
What Is the Granules India Ltd Stock Price Today?
The Granules India Ltd stock price today is 838.65.
What Is the Stock Symbol for Granules India Ltd?
The stock symbol for Granules India Ltd is "GRAN."
What Stock Exchange Does Granules India Ltd Trade On?
Granules India Ltd is listed and trades on the NSE stock exchange.
Is Granules India Ltd a Good Stock to Buy?
Determining whether Granules India Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the GRAN quote. (ISIN: INE101D01020)
What Is the Granules India Ltd Stock Price Today?
The Granules India Ltd stock price today is 838.65.
What Is the Stock Symbol for Granules India Ltd?
The stock symbol for Granules India Ltd is "GRAN."
What Stock Exchange Does Granules India Ltd Trade On?
Granules India Ltd is listed and trades on the NSE stock exchange.
Is Granules India Ltd a Good Stock to Buy?
Determining whether Granules India Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the GRAN quote. (ISIN: INE101D01020)
838.65
-6.45(-0.76%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
835.05
858.15
52 wk Range
434.00
910.00
GRAN is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
835.05858.15
52 wk Range
434.00910.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.21%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.21%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
GRAN Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Prominent player in the Pharmaceuticals industry
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Sell
Moving Averages
Sell
Granules India Ltd Earnings Call Summary for Q1/2027
- Granules India posted record Q1 FY2027 results with revenue up 22% YoY to ₹1,477 crores; PAT surged 60% to ₹180 crores on margin expansion.
- EBITDA margin widened 256 bps to 22.9%; net debt plunged 75% to ₹1,012M from ₹4,021M, achieving near debt-free status with 0.07x leverage.
- Complex generics now comprise 50% of finished dosage sales vs. 39% prior year; company ranked 27th among U.S. generic players, up from 74th.
- Management guides EBITDA margins at 22-23% range; nine product launches await FDA clearance for Gagillapur plant with capex held at ₹600 crores.
- Peptide CDMO targets $50M revenue at 30%+ margins mid-plan; first oncology product expected FY2028-2029 with controlled substance launches in FY2028.
Last Updated: 2026-07-21, 08:44 a/m
Read Full TranscriptEarnings
Latest Release
Jul 21, 2026
EPS / Forecast
6.95 / 7.85
Revenue / Forecast
14.77B / 15.13B
Compare GRAN to Peers and Sector
Metrics to compare | GRAN | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipGRANPeersSector | |
|---|---|---|---|---|
P/E Ratio | 31.1x | 34.0x | −0.4x | |
PEG Ratio | 0.86 | 0.64 | 0.00 | |
Price/Book | 4.1x | 4.6x | 2.6x | |
Price / LTM Sales | 3.7x | 4.7x | 3.0x | |
Upside (Analyst Target) | 10.5% | 1.4% | 51.8% | |
Fair Value Upside | Unlock | −13.2% | 7.2% | Unlock |
Granules India Limited manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates (PFIs), finished dosages (FDs), and peptides CDMO in India and internationally. It offers paracetamol, metformin, guaifenesin, ibuprofen, and methocarbamol, as well as prescription and over-the-counter products. The company also develops and manufactures tablets, capsules, press fits, oral solutions, suspensions, and powder for oral solutions. In addition, it provides development and manufacturing solutions for peptides, peptide fragments, and amino acid derivatives. The company offers its products in various therapeutic categories, including antiretroviral, anti-depressant, antihistamine, anti-diabetic, anti-cancer, multiple sclerosis, anti-thrombocytopenia, anti-ulcer, anti-convulsant, mucolytic/expectorant, anti-hypertensive, muscle relaxant, NSAIDs, anti-fibrotic, and anti-microbial, as well as anti-arrhythmic, CNS stimulant, anti-diarrheal, antihypertensive, uterine stimulant, chelating agent, mineral supplements, CNS depressant, PDE inhibitor, antispasmodic, and anti-viral. Granules India Limited was incorporated in 1984 and is headquartered in Hyderabad, India.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Granules India (GRAN) Stock Price Today?
The Granules India stock price today is 838.65 INR.
What Stock Exchange Does Granules India Trade On?
Granules India is listed and trades on the India National Stock Exchange.
What Is the Stock Symbol for Granules India?
The stock symbol for Granules India is "GRAN."
Does Granules India Pay Dividends? What’s The Current Dividend Yield?
The Granules India dividend yield is 0.21%.
What Is the Granules India Market Cap?
As of today, Granules India market cap is 207.70B INR.
What Is Granules India's Earnings Per Share (TTM)?
The Granules India EPS (TTM) is 26.95.
When Is the Next Granules India Earnings Date?
Granules India will release its next earnings report on Nov 05, 2026.
From a Technical Analysis Perspective, Is GRAN a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has Granules India Stock Split?
Granules India has split 1 times.
How Many Employees Does Granules India Have?
Granules India has 4306 employees.
What is the current trading status of Granules India (GRAN)?
As of Aug 06, 2026, Granules India (GRAN) is trading at a price of 838.65 INR, with a previous close of 845.10 INR. The stock has fluctuated within a day range of 835.05 INR to 858.15 INR, while its 52-week range spans from 434.00 INR to 910.00 INR.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.